NWRD06 DNA Plasmid for HCC After Curative Resection.

NCT07324304 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

BIOLOGICAL: NWRD06 administered by electroporation

Sponsor

Newish Technology (Beijing) Co., Ltd.